RedHill Biopharma Profile

USD 0.04  0.77%
4.84Last Month High 5.52 
5.11Trading Day  High 5.31 

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 12 people. RedHill Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 102.36 M. RedHill Biopharma Ltd has 171.68 M outstanding shares of which 809.46 K shares are at this time shorted by private and institutional investors with about 3.39 trading days to cover. Redhill Biopharma currently holds about 39.44 M in cash with (40.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3.
Check RedHill Biopharma Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Orbimed Advisors LlcCommon Shares564.9 K6.1 M
Menora Mivtachim Holdings LtdCommon Shares421 K4.6 M
View RedHill Biopharma Diagnostics

Selected RedHill Biopharma Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

RedHill Biopharma Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 41% 
Equity ratings for RedHill Biopharma Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, orallyadministered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameRedHill Biopharma Ltd
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressTel Aviv,
Foreign Associate  Israel
ExchangeNasdaq Capital Markets
IndustryPharmaceutical Products
Contact Number972 3 541 3131
CurrencyUSD - US Dollar


RedHill Biopharma Analyst Recommendations
Target PriceAdvice# of Analysts
31.67Strong Buy3Odds
RedHill Biopharma Ltd current and past analyst recommendations published by number of research institutions as well as average analyst consensus
RedHill Biopharma Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


RedHill Biopharma Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.63February 23, 2017
RedHill Biopharma Ltd normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate